228 related articles for article (PubMed ID: 22514277)
1. p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.
Hamard PJ; Lukin DJ; Manfredi JJ
J Biol Chem; 2012 Jun; 287(26):22397-407. PubMed ID: 22514277
[TBL] [Abstract][Full Text] [Related]
2. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
3. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.
Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T
Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967
[TBL] [Abstract][Full Text] [Related]
4. p53 requires an intact C-terminal domain for DNA binding and transactivation.
Kim H; Kim K; Choi J; Heo K; Baek HJ; Roeder RG; An W
J Mol Biol; 2012 Feb; 415(5):843-54. PubMed ID: 22178617
[TBL] [Abstract][Full Text] [Related]
5. p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
Yakovleva T; Pramanik A; Kawasaki T; Tan-No K; Gileva I; Lindegren H; Langel U; Ekstrom TJ; Rigler R; Terenius L; Bakalkin G
J Biol Chem; 2001 May; 276(19):15650-8. PubMed ID: 11279079
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
7. The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.
Laptenko O; Shiff I; Freed-Pastor W; Zupnick A; Mattia M; Freulich E; Shamir I; Kadouri N; Kahan T; Manfredi J; Simon I; Prives C
Mol Cell; 2015 Mar; 57(6):1034-1046. PubMed ID: 25794615
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
9. Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
Rajagopalan S; Andreeva A; Rutherford TJ; Fersht AR
Proc Natl Acad Sci U S A; 2010 May; 107(19):8587-92. PubMed ID: 20421506
[TBL] [Abstract][Full Text] [Related]
10. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
12. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
13. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
14. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a distinct inhibitory factor in the regulation of p53 functional activity.
Wiederschain D; Gu J; Yuan ZM
J Biol Chem; 2001 Jul; 276(30):27999-8005. PubMed ID: 11382762
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for gene activation by p53 family members.
Scoumanne A; Harms KL; Chen X
Cancer Biol Ther; 2005 Nov; 4(11):1178-85. PubMed ID: 16294021
[TBL] [Abstract][Full Text] [Related]
17. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
Golubovskaya VM; Finch R; Cance WG
J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
[TBL] [Abstract][Full Text] [Related]
19. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
